Compare Tenet Healthcare Corporation (THC) vs Weibo Corp (WB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Tenet Healthcare Corporation vs Weibo Corp — how do they compare? Tenet Healthcare Corporation trades at $260 (market cap $20.92B), while Weibo Corp trades at $6.46 (market cap $1.57B). The key difference: Tenet Healthcare Corporation is far larger — about 13.3× Weibo Corp's market cap, and Weibo Corp pays a 9.41% dividend while Tenet Healthcare Corporation pays none. Which is the better fit depends on your goals — on Pluang, investors hold Tenet Healthcare Corporation for 15 Days and Weibo Corp for 102 Days on average.
| THC | WB | |
|---|---|---|
Market Cap | $20.92B | $1.57B |
Volume | 455,764 | 947,144 |
Sector | Health | Media |
52-Week High | $280.77 | $12.37 |
52-Week Low | $161.37 | $6.33 |
Typical Hold Time | 15 Days | 102 Days |
Enterprise Value | $32.00B | $799.15M |
Dividend Yield | — | 9.41% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Tenet Healthcare (THC) trades at $259.83, up 0.53% with strong technical momentum and bullish moving average signals. The company demonstrates robust fundamentals with consistent earnings beats (Q4 2025-Q2 2026), 82.83% gross margins, and 53.31% ROE. Recent news highlights strong cash flow supporting capital returns, with Q3 2026 results expected October 29, 2026.
THC presents compelling value with a 10.04 P/E ratio and 81.25% analyst buy ratings. Upside potential to $283.36 consensus target exists, though negative cash flow trends and insider selling warrant monitoring. The stock's premium valuation (P/B 4.49) requires sustained execution amid healthcare sector volatility.
Weibo (WB) trades at $6.44, down 0.77% on the day, with a bearish technical signal from moving averages. The stock shows attractive valuation metrics with a P/E of 5.36 and P/B of 0.4, while maintaining strong profitability with 73.36% gross margins and 17.78% net income margin. Recent Q2 2026 earnings beat expectations with $0.38 EPS versus $0.36 expected, though Q1 and Q4 2025 missed estimates. Cash flow trends show volatility, with 2024 net cash flow negative $694 million but improving to positive $408 million in 2025.
Weibo presents a deep-value opportunity with compelling valuation multiples, though growth concerns persist amid declining user metrics and advertising revenue challenges. Analyst sentiment remains mixed with 41% buy ratings versus 45% hold, reflecting uncertainty about the company's ability to maintain relevance against intensifying competition. Key risks include stagnating user growth and advertising market pressures, while the current price offers margin of safety for value-oriented investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →About Weibo Corp
Weibo is the largest social media platform in China. As of 2020, Weibo had 521 million monthly active users and 225 million daily active users, many of whom are drawn there by the millions of key opinion leaders in entertainment, sports, and business circles. Sina is the major shareholder, holding 44.7% of shares and with 70.8% voting power.
Read more on WB →
